Related Experiment Video
Updated: Jul 11, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Clinical and radiologic differences between early onset, late onset, and very late onset adult multiple sclerosis
Murali Palathinkara1, Abrahim N Razzak1, Obada E Ababneh2
1Department of Neurology, Division of Neuroimmunology and Multiple Sclerosis, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States.
Background:
Previous studies suggested possible differences in clinical and radiologic characteristics between early-onset multiple sclerosis (EOMS) and late-onset MS (LOMS). However, differences between LOMS and very late onset MS (VLOMS) are largely unknown.
Methods:
We performed a retrospective review of medical records of patients diagnosed with MS between 8/1/2017 and 3/1/2022 at the comprehensive MS center of the Froedtert and Medical College of Wisconsin. We included adult patients with MS diagnosis who were 60 years or older - VLOMS, 50-59 years old at diagnosis - LOMS, or were 18-30 years old at diagnosis - EOMS and had complete imaging and clinical records. Clinical presentation and location of demyelinating lesions at the onset of diagnosis were extracted and compared using the chi-square test, p<0.05.
Results:
A total of 246 newly diagnosed patients were identified. Of which 54 were EOMS, 29 were LOMS, and 35 were VLOMS. The sex ratio was not different between groups. EOMS had a higher percentage of patients who self-identified as black, while LOMS had a higher percentage of patients who self-identified as white. LOMS and VLOMS showed significant differences in the presence of tremors and lesion distribution at the onset. Older onset patients were more likely to present with motor symptoms, sphincter dysfunction, fatigue, and tremor. EOMS was more likely to present with cerebellum and occipital lobe lesions, and lesions were more likely to show contrast enhancement on MRI at diagnosis.
Conclusion:
Our findings revealed novel clinical and imaging characteristics differences between VLOMS and LOMS. The current classification of LOMS may benefit from revision to better align with chronological age classification for old age >60 instead of the current standard in the literature of >50 years.
Insights
This study found distinct clinical and imaging differences between very late onset multiple sclerosis (VLOMS) and late onset multiple sclerosis (LOMS). Current LOMS classification may need revision to better reflect age groups over 60.
Area of Science:
- Neurology
- Radiology
- Epidemiology
Background:
- Previous research indicated variations between early-onset MS (EOMS) and late-onset MS (LOMS).
- Clinical and radiologic distinctions between LOMS and very late onset MS (VLOMS) remain largely unexplored.
Purpose of the Study:
- To investigate and compare the clinical and radiologic characteristics of VLOMS, LOMS, and EOMS.
- To identify differences in symptom presentation and lesion location at diagnosis across different age-of-onset groups for multiple sclerosis.
Main Methods:
- Retrospective review of medical records for 246 newly diagnosed MS patients (EOMS: 18-30, LOMS: 50-59, VLOMS: ≥60 years).
- Analysis of clinical presentation and demyelinating lesion location at diagnosis.
- Comparison using chi-square test with statistical significance set at p<0.05.
Main Results:
- EOMS patients were more likely to have cerebellum/occipital lobe lesions and contrast enhancement on MRI.
- LOMS and VLOMS patients showed differences in tremor presence and lesion distribution.
- Older onset MS patients (LOMS and VLOMS) more frequently presented with motor symptoms, sphincter dysfunction, fatigue, and tremor.
Conclusions:
- Novel clinical and imaging differences were identified between VLOMS and LOMS.
- The current classification of LOMS (≥50 years) may require revision to better align with age-based classifications, particularly for individuals over 60.
Related Concept Videos
Cognitive Development During Adulthood
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

